BCAX Bicara Therapeutics Inc.
Fundamentals / CIK 0002023658 / USDBicara Therapeutics Inc. reported $460.6M in total assets and a net loss of $220.3M through December 31, 2025 from SEC EDGAR filings.
Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open BCAX in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.
-
Revenue FY 2025-- Dec 31, 2025
-
Operating Income FY 2025-$237.0M Operating profit
-
Net Income FY 2025-$220.3M GAAP bottom line
-
Diluted EPS FY 2025-$3.22 Split-adjusted
-
Free Cash Flow FY 2025-$162.8M Operating CF less CapEx
-
Cash & ST Investments Sep 30, 2026$442.3M Total debt: $880K
Annual revenue and net income
3 fiscal years (2023 to 2025), reported in USD.
Financial statements and ratios
Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.
Income Statement (Annual) · Reported in USD · Newest filing period first.
| Income Statement | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|
| Research & Development | -- | $63.60M | $30.60M |
| Total Operating Expenses | $155.6M | $82.39M | $39.89M |
| Operating Income | -$155.6M | -$82.39M | -$39.89M |
| EBITDA | -$155.5M | -$82.33M | -$39.87M |
| Interest Income | $17.87M | $14.58M | $1.31M |
| Income Before Tax | -$137.7M | -$67.81M | -$51.98M |
| Income Tax Expense | $217K | $187K | $5.0K |
| Net Income | -$137.9M | -$68.00M | -$51.98M |
| Basic EPS | -$2.52 | -$4.05 | -$89.61 |
| Diluted EPS | -$2.52 | -$4.05 | -$89.61 |
| Basic Shares Outstanding | 54.68B | 16.81B | 580.1M |
| Diluted Shares Outstanding | 54.68B | 16.81B | 580.1M |
Income Statement (Quarterly) · Reported in USD · Newest filing period first.
| Income Statement | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Research & Development | -- | -- | -- | -- | $33.00M | $24.80M | $34.30M | $19.90M |
| Total Operating Expenses | $75.71M | $59.95M | $60.24M | $41.12M | $40.68M | $32.02M | $41.79M | $26.64M |
| Operating Income | -$75.71M | -$59.95M | -$60.24M | -$41.12M | -$40.68M | -$32.02M | -$41.79M | -$26.64M |
| EBITDA | -$75.65M | -$59.91M | -$60.20M | -$41.08M | -$40.65M | -$32.00M | -$41.77M | -$26.62M |
| Interest Income | $4.52M | $4.58M | $4.08M | $3.79M | $4.39M | $4.68M | $5.01M | $5.87M |
| Income Before Tax | -$71.19M | -$55.38M | -$56.16M | -$37.33M | -$36.29M | -$27.34M | -$36.77M | -$20.77M |
| Income Tax Expense | $54K | $61K | $52K | $53K | $40K | $52K | $72K | $186K |
| Net Income | -$71.25M | -$55.44M | -$56.21M | -$37.39M | -$36.33M | -$27.39M | -$36.85M | -$20.96M |
| Basic EPS | -$1.04 | -$0.82 | -$0.93 | -- | -$0.67 | -$0.50 | -$0.68 | -- |
| Diluted EPS | -$1.04 | -$0.82 | -$0.93 | -- | -$0.67 | -$0.50 | -$0.68 | -- |
| Basic Shares Outstanding | 68.4M | 67.9M | 60.7M | -- | 54.6M | 54.5M | 54.5M | -- |
| Diluted Shares Outstanding | 68.4M | 67.9M | 60.7M | -- | 54.6M | 54.5M | 54.5M | -- |
Balance Sheet (Annual) · Reported in USD · Newest filing period first.
| Balance Sheet | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|
| Cash & Cash Equivalents | $96.69M | $489.7M | $230.4M |
| Short-Term Investments | $318.1M | $0 | -- |
| Cash & Short-Term Investments | $414.8M | $489.7M | $230.4M |
| Total Current Assets | $422.1M | $502.5M | $231.1M |
| Property, Plant & Equipment, Net | $330K | $155K | $202K |
| Long-Term Investments | -- | $0 | -- |
| Other Non-Current Assets | $6.91M | $6.62M | $2.09M |
| Total Non-Current Assets | $8.94M | $7.46M | $2.91M |
| Total Assets | $431.0M | $510.0M | $234.0M |
| Total Current Liabilities | $28.95M | $17.99M | $15.09M |
| Other Non-Current Liabilities | -- | $0 | $17K |
| Total Non-Current Liabilities | $593K | $131K | $389K |
| Total Liabilities | $29.54M | $18.12M | $15.47M |
| Total Debt (incl. Leases) | $1.71M | $738K | $657K |
| Common Stock | $7.0K | $7.0K | $2.0K |
| Retained Earnings | -$359.0M | -$221.0M | -$153.0M |
| Accumulated Other Comp. Income | $243K | $0 | -- |
| Total Stockholders' Equity | $401.5M | $491.9M | -$148.8M |
| Total Equity | $401.5M | $491.9M | -$148.8M |
Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.
| Balance Sheet | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Cash & Cash Equivalents | $82.02M | $96.60M | $323.5M | $96.69M | $171.7M | $436.6M | $462.1M | $489.7M |
| Short-Term Investments | $360.3M | $400.7M | $216.3M | $318.1M | $118.5M | -- | -- | $0 |
| Cash & Short-Term Investments | $442.3M | $497.3M | $539.8M | $414.8M | $290.2M | $436.6M | $462.1M | $489.7M |
| Total Current Assets | $451.4M | $503.8M | $544.9M | $422.1M | $297.4M | $444.4M | $470.8M | $502.5M |
| Property, Plant & Equipment, Net | $965K | $362K | $346K | $330K | $135K | $117K | $136K | $155K |
| Long-Term Investments | -- | -- | -- | -- | $117.4M | -- | -- | $0 |
| Other Non-Current Assets | $7.54M | $6.91M | $6.91M | $6.91M | $7.79M | $6.84M | $6.63M | $6.62M |
| Total Non-Current Assets | $9.23M | $8.42M | $8.68M | $8.94M | $127.3M | $9.20M | $7.32M | $7.46M |
| Total Assets | $460.6M | $512.2M | $553.6M | $431.0M | $424.7M | $453.6M | $478.1M | $510.0M |
| Total Current Liabilities | $51.23M | $43.48M | $39.34M | $28.95M | $21.03M | $17.23M | $19.12M | $17.99M |
| Other Non-Current Liabilities | -- | -- | -- | -- | -- | -- | -- | $0 |
| Total Non-Current Liabilities | $0 | $0 | $301K | $593K | $880K | $1.16M | $0 | $131K |
| Total Liabilities | $51.23M | $43.48M | $39.64M | $29.54M | $21.91M | $18.39M | $19.12M | $18.12M |
| Total Debt (incl. Leases) | $880K | $1.16M | $1.44M | $1.71M | $1.98M | $2.24M | $591K | $738K |
| Common Stock | $8.0K | $8.0K | $8.0K | $7.0K | $7.0K | $7.0K | $7.0K | $7.0K |
| Retained Earnings | -$541.9M | -$470.6M | -$415.2M | -$359.0M | -$321.6M | -$285.2M | -$257.9M | -$221.0M |
| Accumulated Other Comp. Income | -$1.87M | -$567K | -$243K | $243K | -$136K | -- | -- | $0 |
| Total Stockholders' Equity | $409.4M | $468.8M | $514.0M | $401.5M | $402.8M | $435.2M | $459.0M | $491.9M |
| Total Equity | $409.4M | $468.8M | $514.0M | $401.5M | $402.8M | $435.2M | $459.0M | $491.9M |
Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.
| Cash Flow Statement | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|
| Net Income | -$137.9M | -$68.00M | -$51.98M |
| Depreciation & Amortization | $105K | $56K | $19K |
| Stock-Based Compensation | $15.01M | $7.40M | $1.90M |
| Operating Cash Flow | -$106.8M | -$74.75M | -$45.63M |
| Capital Expenditure | -$280K | -$71K | -$586K |
| Free Cash Flow | -$107.1M | -$74.82M | -$46.21M |
| Purchases of Investments | -$318.2M | $0 | -- |
| Investing Cash Flow | -$318.5M | -$9.0K | -$586K |
| Common Stock Issued | $29.50M | $332.4M | $0 |
| Financing Cash Flow | $32.26M | $334.0M | $272.5M |
| Net Change in Cash | -$393.0M | $259.3M | $226.3M |
Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.
| Cash Flow Statement | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Net Income | -$71.25M | -$55.44M | -$56.21M | -$37.39M | -$36.33M | -$27.39M | -$36.85M | -$20.96M |
| Depreciation & Amortization | $60K | $44K | $44K | $43K | $24K | $19K | $19K | $15K |
| Stock-Based Compensation | $9.98M | $8.24M | $5.86M | $4.45M | $3.61M | $3.49M | $3.45M | $3.18M |
| Operating Cash Flow | -$56.13M | -$44.21M | -$37.51M | -$23.89M | -$29.25M | -$25.59M | -$28.11M | -$30.03M |
| Capital Expenditure | -$663K | -$60K | -$60K | -$238K | -$42K | $0 | $0 | -$40K |
| Free Cash Flow | -$56.79M | -$44.27M | -$37.57M | -$24.12M | -$29.29M | -$25.59M | -$28.11M | -$30.07M |
| Sales & Maturities of Investments | $39.00M | $60.00M | $101.0M | -- | $0 | $0 | $0 | -- |
| Investing Cash Flow | $38.34M | -$185.0M | $100.9M | -$82.33M | -$236.1M | $0 | $0 | -$40K |
| Common Stock Issued | $0 | $0 | $161.8M | $29.50M | $0 | $0 | $0 | -- |
| Financing Cash Flow | $3.21M | $2.33M | $163.3M | $31.23M | $436K | $135K | $460K | -$975K |
| Net Change in Cash | -$14.58M | -$226.9M | $226.8M | -$74.99M | -$264.9M | -$25.46M | -$27.65M | -$31.05M |
Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.
| Ratios & Growth | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|
| Return on Equity (ROE) | -34.4% | -13.8% | -- |
| Return on Assets (ROA) | -32.0% | -13.3% | -22.2% |
| Current Ratio | 14.58x | 27.93x | 15.32x |
| Quick Ratio | 14.33x | 27.22x | 15.28x |
| Debt to Equity | 0.00x | 0.00x | -- |
Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.
| Ratios & Growth | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Return on Equity (ROE) | -53.8% | -39.5% | -30.6% | -34.4% | -30.2% | -23.6% | -20.1% | -13.8% |
| Return on Assets (ROA) | -47.8% | -36.2% | -28.4% | -32.0% | -28.6% | -22.6% | -19.3% | -13.3% |
| Current Ratio | 8.81x | 11.59x | 13.85x | 14.58x | 14.14x | 25.80x | 24.62x | 27.93x |
| Quick Ratio | 8.63x | 11.44x | 13.72x | 14.33x | 13.80x | 25.34x | 24.17x | 27.22x |
| Debt to Equity | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.01x | 0.00x | 0.00x |